Using our experimental assay directly targeting NAMPT, we identified a highly potent NAMPT inhibitor MS0 and demonstrated its activity against multiple human cancer cell lines, which was granted with China Patent ZL201110447488.98. This evidence concerns the gene NAMPT and cancer.